The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.

Walid ChayouaHilde KelchtermansJean-Christophe GrisGary W MooreJacek MusiałDenis WahlPhilip G de GrootBas de LaatKatrien M J Devreese

Published in: Journal of thrombosis and haemostasis : JTH (2019)

Our data support testing for aCL and aβ2GPI IgM in women suspected of obstetric APS. However, no added value was found for testing IgM in patients suspected of thrombotic APS. Still, IgM aPL might be useful as a second-line test to improve thrombotic risk stratification.

Keyphrases

end stage renal disease
pulmonary embolism
ejection fraction
newly diagnosed
chronic kidney disease
pregnant women
prognostic factors
polycystic ovary syndrome
big data
type diabetes
electronic health record
skeletal muscle
deep learning
cervical cancer screening